Correlation Between Indraprastha Medical and Kilitch Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Indraprastha Medical and Kilitch Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indraprastha Medical and Kilitch Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indraprastha Medical and Kilitch Drugs Limited, you can compare the effects of market volatilities on Indraprastha Medical and Kilitch Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indraprastha Medical with a short position of Kilitch Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indraprastha Medical and Kilitch Drugs.

Diversification Opportunities for Indraprastha Medical and Kilitch Drugs

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Indraprastha and Kilitch is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Indraprastha Medical and Kilitch Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kilitch Drugs Limited and Indraprastha Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indraprastha Medical are associated (or correlated) with Kilitch Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kilitch Drugs Limited has no effect on the direction of Indraprastha Medical i.e., Indraprastha Medical and Kilitch Drugs go up and down completely randomly.

Pair Corralation between Indraprastha Medical and Kilitch Drugs

Assuming the 90 days trading horizon Indraprastha Medical is expected to generate 1.09 times more return on investment than Kilitch Drugs. However, Indraprastha Medical is 1.09 times more volatile than Kilitch Drugs Limited. It trades about 0.21 of its potential returns per unit of risk. Kilitch Drugs Limited is currently generating about -0.01 per unit of risk. If you would invest  40,670  in Indraprastha Medical on September 1, 2024 and sell it today you would earn a total of  5,305  from holding Indraprastha Medical or generate 13.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Indraprastha Medical  vs.  Kilitch Drugs Limited

 Performance 
       Timeline  
Indraprastha Medical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Indraprastha Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Indraprastha Medical exhibited solid returns over the last few months and may actually be approaching a breakup point.
Kilitch Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Indraprastha Medical and Kilitch Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Indraprastha Medical and Kilitch Drugs

The main advantage of trading using opposite Indraprastha Medical and Kilitch Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indraprastha Medical position performs unexpectedly, Kilitch Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kilitch Drugs will offset losses from the drop in Kilitch Drugs' long position.
The idea behind Indraprastha Medical and Kilitch Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets